# The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure

## TL;DR

This case study explores two treatment approaches for a rare coagulation disorder in an elderly patient with complex medical history.

## Contribution

Presents a novel case of managing enhanced-fibrinolytic DIC through tailored surgical and medical strategies in a high-risk patient.

## Key findings

- Surgical intervention temporarily controlled hemorrhage in a patient with enhanced-fibrinolytic DIC.
- Combination of anticoagulant and antifibrinolytic agents successfully managed recurrent DIC symptoms.
- Tailored therapy based on patient comorbidities is crucial for managing complex DIC cases.

## Abstract

Management of the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by aortic disorders is the two strategies of surgical intervention and medical treatment based on the patient’s age and comorbidities.

An 81-year-old woman with a history of two previous aortic surgeries and chronic heart and renal failure was admitted for uncontrollable subcutaneous hemorrhage. The hemorrhage was caused by the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by periprosthetic graft hematoma after aortic replacement for Stanford type A aortic dissection. Open thoracic hemostasis temporarily controlled the subcutaneous hemorrhage, but she was readmitted for the recurrence seven months after discharge. On the second admission, the combination of anticoagulant and antifibrinolytic agents was successful.

Management of the enhanced-fibrinolytic type of DIC caused by aortic disorders is important of a successful combination of surgical and medical therapy tailored the patient’s condition.